ArticleBMC cancer2025
Cross-tissue transcriptome-wide association studies identify genetic susceptibility genes for prostate cancer.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cumulative evidence for associations between matrix metalloproteinase-1, -3 and -8 variants and cancer risk.Oncology letters · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundDespite significantPlease check if article title presented correctly. advances made by genome-wide association studies (GWAS) in the genetic exploration of tumors such as prostate cancer (PCa), the precise pathogenic genes and underlying biological mechanisms of PCa remain unclear.
methodsTo address this complex issue, we used a cross-tissue transcriptome-wide association study (TWAS) strategy within the Unified Test for Molecular Signatures (UTMOST) framework. This approach integrated GWAS summary statistics from 122,188 PCa patients and 604,640 controls with extensive gene expression data from the Genotype-Tissue Expression (GTEx) project. We validated key gene discoveries using three complementary methods: FUSION, FOCUS, and Multi-marker Analysis of GenoMic Annotation (MAGMA). Additionally, MAGMA was used to examine the tissue and functional level enrichment of single nucleotide polymorphisms (SNPs) associated with PCa. Conditional and joint analysis, as well as fine mapping techniques, were employed to deepen our understanding of PCa's genetic architecture. To establish causal relationships, we conducted Mendelian randomization analysis, while colocalization analysis was used to identify potential shared SNPs between key genes and PCa risk.
resultsThrough the comprehensive application of four TWAS methods, we identified 13 potential susceptibility genes closely associated with PCa risk. Mendelian randomization analysis confirmed direct causal links between the WDPCP, RIF1, POLI, HAAO, GGCX and CASP10 genes and PCa. Colocalization analysis further revealed that CASP10 (rs6735656), GGCX (rs2028900) may share genetic signals between GWAS and expression quantitative trait loci (eQTL), indicating common pathways in PCa pathogenesis.
conclusionThis study identified 13 new susceptibility genes significantly associated with PCa risk and provided new insights into the genetic basis of PCa, contributing to a more comprehensive understanding of its complex genetic structure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.